Welcome to Hot Topics! In this episode, host Gabrielle Crichlow invites Dr. Jasmine Ebott, a college friend and fellow lifetime National Society of Collegiate Scholars member, to delve into the important subject of fibroids.

Fibroids, also known as uterine leiomyomas, are the focus of this enlightening conversation. Gabrielle and Dr. Ebott aim to provide information, raise awareness, and address the common misconceptions surrounding fibroids.

Listeners will gain a deeper understanding of fibroids, including their symptoms and prevalence, with a specific emphasis on their higher occurrence in Black and Hispanic women. While the exact reasons for this disparity remain unknown, the speakers shed light on the importance of acknowledging and addressing this issue.

Gabrielle and Dr. Ebott clarify that fibroids are non-cancerous growths that develop in the uterus and do not spread to other parts of the body. They explore the potential connection between fibroids and hormone imbalances, as well as the possibility of shrinking fibroids through hormonal treatments.

Throughout the episode, the speakers discuss various treatment options for fibroids, such as injections, medications, myomectomy, hysterectomy, and uterine artery embolization. Dr. Ebott explains the goals of these treatments, which include alleviating symptoms and creating a favorable environment for potential pregnancy. The importance of considering individual circumstances and future fertility goals when choosing a treatment option is emphasized, along with the potential risks and benefits associated with each approach.

The conversation also touches on the recovery process after surgery, the need for personalized decision-making, and the significance of seeking professional guidance when dealing with fibroids. Additionally, the speakers briefly mention the connection between fibroids and fertility, reassuring listeners that having fibroids does not necessarily eliminate the possibility of getting pregnant.

Overall, this episode provides valuable information and personal insights into the world of fibroids. Whether you're seeking to expand your knowledge or looking for support in managing this health issue, Gabrielle and Dr. Ebott's discussions will educate and empower you. Tune in now to join the conversation and gain a deeper understanding of fibroids.

Who is Dr. Jasmine Ebott?
Dr. Jasmine Ebott is a gynecologic oncology fellow at Brown University/The Program in Women's Oncology at Women & Infants Hospital. After graduation, she will be joining Maryland Hematology/Oncology. She plans to engage with the local community to improve awareness around early signs of gynecologic malignancies and increase access to clinical trials.

You can find Jasmine:
On Facebook: https://www.facebook.com/jasmine.hines.503
On Instagram: https://www.instagram.com/jazebott/
On X: https://twitter.com/EbottJasmine
On TikTok: https://www.tiktok.com/@jasmineebott

Watch this episode on YouTube: https://youtube.com/live/C39RFB_aCUg
********************************************
Follow A Step Ahead Tutoring Services:
On Facebook: https://www.facebook.com/astepaheadtutoringservices
On Instagram: https://www.instagram.com/astepaheadtutoringservices
On X: https://www.x.com/ASATS2013
On YouTube: https://www.youtube.com/@astepaheadtutoringservices
On TikTok: https://www.tiktok.com/@asats2013
On Eventbrite: https://astepaheadtutoringservices.eventbrite.com

Visit our website: https://www.astepaheadtutoringservices.com

Sign up for our email list: https://squareup.com/outreach/a41DaE/subscribe

Sign up for our text list: https://eztxt.s3.amazonaws.com/534571/widgets/61fc686d8d6665.90336120.html

Check out our entire "Hot Topics!" podcast: https://www.astepaheadtutoringservices.com/hottopicspodcast

Support us:
Cash App: https://cash.app/$ASATS2013
PayPal: https://paypal.me/ASATS2013
Venmo: https://venmo.com/u/ASATS2013
Zelle: success@astepaheadtutoringservices.com

You can also become a supporter of this podcast: https://www.spreaker.com/podcast/hot-topics--5600971/support 

Original date of episode: February 13, 2024